Franz R. Eberli - Concepedia

Author

Franz R. Eberli

Triemli Hospital ORCID

Also Known As

B Stähli, Eberli, F, Eberli, F., Eberli, Franz, Eberli, Franz R, Eberli, R, F EBERLI, F Eberli, F R Eberli, F. Eberli

293

Publications

18.6K

Citations

H-Index

Concepts

All Affiliations

Triemli Hospital University Hospital of Bern University Hospital of Zurich University of Zurich Institute of Social and Preventive Medicine

About

Franz R. Eberli is an author at Triemli Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	44	5K
2	Health Sciences	6	6	457
3	Engineering	1	1	218
4	Language Studies	1	1	16
5	Management	1	1	218

Franz R. Eberli

128

Publications

13.1K

Citations

H-Index

Page 1

	Year	Citations
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial Raimund Erbel, Carlo Di Mario, Jozef Bartúnek, The Lancet Coronary ArteriesPercutaneous Coronary InterventionCardiovascular DiseaseTemporary ScaffoldingLumen-apposing Metal Stent	2007	895
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk Philip Urban, Ian T. Meredith, Alexandre Abizaid, New England Journal of Medicine	2015	790
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Stephan Windecker, Patrick W. Serruys, Simon Wandel, The Lancet Percutaneous Coronary InterventionEndovascular TechniqueCardiovascular DiseaseAtherosclerosisLumen-apposing Metal Stent	2008	650
Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization Stephan Windecker, Andréa Remondino, Franz R. Eberli, New England Journal of Medicine	2005	591
Percutaneous Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism Stephan Windecker, Andreas Wahl, Tushar Chatterjee, Circulation	2000	438
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial Giulio Stefanini, Bindu Kalesan, Patrick W. Serruys, The Lancet Percutaneous Coronary InterventionEndovascular TechniqueCardiovascular DiseaseLong-term Clinical OutcomesLumen-apposing Metal Stent	2011	350
Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Patrick W. Serruys, Vasim Farooq, Bindu Kalesan, JACC: Cardiovascular Interventions Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseAtherosclerosisBiomedical Engineering	2013	328
Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease Christian Seiler, Tilmann Pohl, Kerstin Wustmann, Circulation	2001	325
Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012 Dragana Radovanović, Burkhardt Seifert, Philip Urban, Heart	2013	311
Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction Willibald Maier, Lukas Altwegg, Roberto Corti, Circulation	2005	293

Page 1